Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 5 February 2021) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

 (PDF, 3MB, 220 pages) 

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website

 

 

Export 8 results:
Author Title [ Type(Desc)] Year
Filters: Author is Davies, M. J.  [Clear All Filters]
Journal Article
C. A. Lawson, Zaccardi, F., Squire, I., Ling, S., Davies, M. J., Lam, C. S. P., Mamas, M. A., Khunti, K., and Kadam, U. T., 20-year trends in cause-specific heart failure outcomes by sex, socioeconomic status, and place of diagnosis: a population-based study, Lancet Public Health, vol. 4, pp. e406-e420, 2019.
B. Coles, Zaccardi, F., Ling, S., Davies, M. J., Samani, N. J., and Khunti, K., Cardiovascular events and mortality in people with and without type 2 diabetes: An observational study in a contemporary multi-ethnic population, J Diabetes Investig, 2020.
K. Khunti, Wolden, M. L., Thorsted, B. L., Andersen, M., and Davies, M. J., Clinical inertia in people with type 2 diabetes: a retrospective cohort study of more than 80,000 people, Diabetes Care, vol. 36, pp. 3411-7, 2013.
K. Khunti, Nikolajsen, A., Thorsted, B. L., Andersen, M., Davies, M. J., and Paul, S. K., Clinical inertia with regard to intensifying therapy in people with type 2 diabetes treated with basal insulin, Diabetes Obes Metab, vol. 18, pp. 401-9, 2016.
F. Zaccardi, Jacquot, E., Cortese, V., Tyrer, F., Seidu, S., Davies, M. J., and Khunti, K., Comparative effectiveness of gliclazide modified release vs sitagliptin as second-line treatment after metformin monotherapy in patients with uncontrolled type 2 diabetes, Diabetes Obes Metab, 2020.
B. Coles, Khunti, K., Booth, S., Zaccardi, F., Davies, M. J., and Gray, L. J., Prediction of type 2 diabetes risk in people with non-diabetic hyperglycaemia: model derivation and validation using UK primary care data, BMJ Open, vol. 10, p. e037937, 2020.
F. Zaccardi, Husemoen, L. L. Nystrup, Thorsted, B. L., Webb, D. R., Paul, S. K., Davies, M. J., and Khunti, K., Selectivity of beta-blockers, cardiovascular and all-cause mortality in people with hypoglycaemia: An observational study, Nutr Metab Cardiovasc Dis, vol. 29, pp. 481-488, 2019.
F. Zaccardi, Ling, S., Lawson, C., Davies, M. J., and Khunti, K., Severe hypoglycaemia and absolute risk of cause-specific mortality in individuals with type 2 diabetes: a UK primary care observational study, Diabetologia, 2020.
[Page last reviewed 4 February 2021]